About

The summary of the conference is available on this webpage where you are able to:

• discover the services and products of the exhibitors and media partners,

• download the conference program,

• see pictures of the event,

• contact the speakers to carry on the conversations from the in-person event and ask for a copy of their slides.

7 take-aways from SMI.London 2025: SMI.London 2025 happened last week and was spectacular. Thank you to Suzanne @GetAhead and her team for a flawless organisation. Watch out for speakers’ slides and post event news at www.SMI.London.  Our 7 (yes, 7! It was a rich event) take-aways are:

• we barely heard about asthma and COPD. SMI therapies are ahead of the curve and looking at lung cancer, GLP-1 treatments, vaccination, pulmonary hypertension,

• nasal SMIs are in development. This is an expansion of the traditional SMIs field and very exciting to see happening,

• with Trixeo HFO1234ze pMDI on the market at £44 per month in the UK, the transition of pMDI >> SMI now makes financial sense,

• water has a global warming potential of 0. SMIs offer the lowest global warming potential with no need for complex filling plants, 

• how many academic centres are studying SMIs? We counted 12 across the globe and growing,

• the supply chain of SMIs is clear and sorted, from formulation screening, filling, device supply and clinical trials,

• what is needed is an SMI monograph or guidance. Let’s get drafting.

Inhalation Drug Delivery: We Make It Better.